German life sciences and technology giant Merck announced it is expanding its membrane and filtration manufacturing capabilities in Ireland.
The company will invest €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork.
The investment will create more than 370 permanent jobs by the end of 2027.
At Blarney Business Park, Merck will also build a new filtration manufacturing facility for almost €150 million.
An Taoiseach Micheál Martin said: “This investment, the largest in the history of Merck Life Science, speaks volumes about our capacity to provide the right conditions for multinational organisations to grow their operations.
“Ireland’s development of a strong life sciences ecosystem has been one of our greatest economic successes.
“I am delighted that Merck has chosen Cork for its latest investment. I wish the team continued success, as they work towards improving lives around the world.”
Merck Life Science CEO Matthias Heinzel said: “Ireland is central to our strategy to drive long-term growth and expand our global leadership position in Life Science.
“The investment in Cork is the biggest site investment in the history of our Life Science business and will accelerate the delivery of the critical products, technologies and services our customers need to fight the world’s toughest health challenges, including COVID-19.”
Martin McAuliffe, Managing Director and Head of Cork Operations at Merck, said: “Today’s announcement of the decision to construct a new membrane manufacturing facility in Carrigtwohill and the development of a new filtration manufacturing facility in Blarney is a testament to the capability, hard work and dedication of all our colleagues here in Cork.
“Beyond that, it is a statement of Merck’s commitment to our Irish operations. These new investments secure a bright future for Merck in Cork and enable us to expand our capabilities here, generating new employment opportunities in future technology.”
IDA Ireland CEO Martin Shanahan said: “This significant investment announced today by Merck – the largest the global Life Sciences and Technology business has ever made in a single site, is very welcome.
“This announcement demonstrates the continued growth and success of Ireland’s Life Sciences sector and indeed IDA Ireland’s continued commitment to winning jobs and investment for regional locations.
“These developments in Carrigtwohill and Blarney will have a significant positive economic impact on the South West region, during the initial construction period and also with the number of full-time roles that will be created as a result of the expansion.
“Merck’s decision to increase its footprint is tangible evidence of the company’s confidence in Ireland’s ability to provide access to world-class talent.
“I want to assure the team at Merck of IDA Ireland’s continued support and wish them every success with this major investment.”